These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 8066680

  • 1. Living-related kidney transplantation using low-dose triple immunosuppression.
    Rashid HU, Rahman M, Wahab MA, Kibria G, Rahman S, Jinnat S.
    Transplant Proc; 1994 Aug; 26(4):2089. PubMed ID: 8066680
    [No Abstract] [Full Text] [Related]

  • 2. Prospective randomized study of triple vs conventional immunosuppression in living donor kidney transplantation.
    Ghoneim MA, Sobh MA, Shokeir AA, Bakr MA, el-Sherif A, Foda MA.
    Transplant Proc; 1993 Jun; 25(3):2243-5. PubMed ID: 8516887
    [No Abstract] [Full Text] [Related]

  • 3. Retrospective study of cyclosporine-prednisolone versus cyclosporine-azathioprine-prednisolone immunosuppression in living donor kidney transplantation.
    Reissi D, Bardideh A, Samadzadeh B, Razi A.
    Transplant Proc; 1995 Oct; 27(5):2685-6. PubMed ID: 7482875
    [No Abstract] [Full Text] [Related]

  • 4. Kidney transplantation at one center: 1-year results.
    Haberal M, Bilgin N, Karakayali H, Arslan G, Büyükpamukçu N, Velidedeoğlu E, Turan M, Akkoç H, Moray G, Tezel E.
    Transplant Proc; 1996 Feb; 28(1):410-1. PubMed ID: 8644295
    [No Abstract] [Full Text] [Related]

  • 5. Immunosuppression for recipients of kidneys from non-heart-beating donors: comparison of triple therapy and OKT3 regimens.
    Kehinde EO, Wheatley T, Feehally J, Nicholson ML, Veitch PS, Bell PR.
    Transplant Proc; 1996 Jun; 28(3):1338-9. PubMed ID: 8658684
    [No Abstract] [Full Text] [Related]

  • 6. Different trends in immunosuppression: 10 years' experience with cyclosporine after living related donor renal transplantation.
    Bakr MA, Sally S, Foda MA, Sobh MA, el-Sherif AK, Ghoneim MA.
    Transplant Proc; 1994 Dec; 26(6):3163-6. PubMed ID: 7998104
    [No Abstract] [Full Text] [Related]

  • 7. Cadaveric renal transplantation with cyclosporine monotherapy.
    Aikawa A, Sells RA, Bakran A, Tewari A.
    Transplant Proc; 1994 Aug; 26(4):1915-6. PubMed ID: 8066623
    [No Abstract] [Full Text] [Related]

  • 8. Comparison between donor-specific transfusions with conventional immunosuppression and triple therapy including cyclosporine in living related donor kidney transplantation.
    Arbelaez M, Mejia G, Henao JE, Garcia A, Arango JL, Velasquez A, Restrepo J, Garcia LF.
    Transplant Proc; 1992 Dec; 24(6):3096-7. PubMed ID: 1466072
    [No Abstract] [Full Text] [Related]

  • 9. Improved success of pediatric renal transplantation.
    Seki T, Takeuchi I, Tanda K, Chikaraishi T, Kanagawa K, Nonomura K, Togashi M, Koyanagi T.
    Transplant Proc; 1994 Aug; 26(4):2067-8. PubMed ID: 8066672
    [No Abstract] [Full Text] [Related]

  • 10. Living-related and living-unrelated kidney transplantation using low-dose triple immunosuppression.
    Francis DM, Walker RG, Millar RJ, Becker G.
    Transplant Proc; 1992 Oct; 24(5):1887-8. PubMed ID: 1412899
    [No Abstract] [Full Text] [Related]

  • 11. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA, Bakr MA, Fouda MA, Shokeir AA, Bayoumy A, Sobh M, Ghoneim M.
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [Abstract] [Full Text] [Related]

  • 12. High incidence of posttransplant diabetes mellitus in renal transplant recipients on triple-drug immunosuppression.
    Sakhuja V, Sharma UK, Jha V, Minz M, Chugh KS.
    Transplant Proc; 1995 Oct; 27(5):2728-30. PubMed ID: 7482892
    [No Abstract] [Full Text] [Related]

  • 13. Results of clinical renal transplantation in 15 dogs using triple drug immunosuppressive therapy.
    Gregory CR, Kyles AE, Bernsteen L, Mehl M.
    Vet Surg; 2006 Feb; 35(2):105-12. PubMed ID: 16472290
    [Abstract] [Full Text] [Related]

  • 14. Live donor renal transplantation with low-dose triple immunosuppression.
    Francis DM, Millar RJ, Walker RG, Nicholls K, Powell H, Jones C, Kockelbergh R, Becker G.
    Transplant Proc; 1992 Oct; 24(5):2243. PubMed ID: 1413041
    [No Abstract] [Full Text] [Related]

  • 15. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation.
    Kitabayashi K, Munn SR, Sterioff S.
    Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964
    [No Abstract] [Full Text] [Related]

  • 16. Triple therapy with cyclosporine A in kidney transplant patients.
    Matl I, Jirka J, Petrásek R, Vítko S.
    Transplant Proc; 1995 Oct; 27(5):2573. PubMed ID: 7482831
    [No Abstract] [Full Text] [Related]

  • 17. Kidney transplantation in pediatric population.
    Mota C, Henriques C, Sarmento M, Pereira E, Xavier E, Pereira M.
    Transplant Proc; 1994 Oct; 26(5):2768-70. PubMed ID: 7940872
    [No Abstract] [Full Text] [Related]

  • 18. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T, Kapischke M, Busing M.
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [Abstract] [Full Text] [Related]

  • 19. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.
    Giral M, Taddei C, Nguyen JM, Dantal J, Hourmant M, Cantarovich D, Blancho G, Ancelet D, Soulillou JP.
    Clin Transpl; 1996 May; ():257-64. PubMed ID: 9286575
    [Abstract] [Full Text] [Related]

  • 20. Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years.
    MacDonell RC, Van Buren DH, Richie RE, Johnson HK, Nylander WA, Helderman JH, Ynares CM, Trusler LA, Green WF, Crowe DA.
    Transplant Proc; 1994 Oct; 26(5):2518-21. PubMed ID: 7940774
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.